|Articles|December 4, 2020
HIC Analysis of Drug-to-Antibody Ratio
Author(s)Agilent Technologies, Inc.
This application note demonstrates the DAR determination of brentuximab vedotin using HIC. Excellent reproducibility was found with the Agilent 1290 Infinity II Bio LC.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Voices from the Analytical Front Line: Thomas Letzel on Chromatography in 2026
2
GC×GC-TOFMS Volatome Profiling Reveals pH-Dependent VOC Signatures of Malassezia pachydermatis
3
Velaris Announces Acquisition of Markes International
4
Voices from the Analytical Front Line: Tony Edge on Chromatography in 2026
5